Literature DB >> 28684184

Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.

Haiyuan Li1, Jingning Lu2, Xiaofeng Zhou1, Denghua Pan1, Dequan Guo1, Haiying Ling1, Hong Yang3, Yun He1, Gang Chen4.   

Abstract

Previous studies have shown that contrast-enhanced ultrasound (CEUS) can be used quantitatively to analyze microcirculation blood perfusion in hepatocellular carcinoma patients. However, limited data have described the application of CEUS in hepatic microcirculation after liver ischemic-reperfusion injury (IRI). The purpose of this study was to explore the use of CEUS quantitatively to assess liver microcirculation after liver IRI. We randomly sorted 45 New Zealand rabbits into 3 groups (15 in each). Group A was a control group in which the rabbits underwent laparotomy alone. In groups B and C, hepatic blood was blocked for 30 min. Simultaneously, rabbits in group C underwent left lateral lobe resection. After 30 min of ischemia, CEUS was conducted after 0 h, 1 h, 6 h and 24 h of reperfusion in the 3 groups. Time-intensity curves (TICs) for CEUS were constructed and quantitative parameters (maximum intensity [IMAX], rise time [RT], time to peak [TTP] and mean transit time [mTT]) were obtained. In addition, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were computed to estimate liver function before the operation and at 0 h, 1 h, 6 h and 24 h after reperfusion, respectively. Pathologic changes in the liver after reperfusion were also observed. Simultaneously, the correlations between serum transaminase and a variety of quantitative analysis parameters were analyzed. In groups B and C, the IMAX value decreased; whereas RT, TTP, mTT and serum ALT and AST levels increased significantly in comparison with those in group A after 0 h and 1 h of reperfusion. The pathology revealed that erythrocytes were destroyed and microcirculation was disturbed. Then, at 6 h of reperfusion, the IMAX continued to decrease. Additionally, the levels of RT, TTP, mTT and serum ALT and AST increased in comparison with those at 1 h of reperfusion. The pathologic analysis revealed inflammatory cell aggregation and leukocyte infiltration. After 24 h of reperfusion, the IMAX was reduced in comparison with that of the 6-h group. The levels of RT, TTP, mTT and serum ALT and serum AST were increased in comparison with that of the 6-h group. These findings were in accordance with the pathologic analysis. In addition, serum transaminase had a negative correlation with IMAX (p < 0.001) and a positive correlation with RT, TTP and mTT (all p < 0.001). So, in conclusion, the quantitative analysis of CEUS can be used to assess hepatic microcirculation after liver IRI.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Ischemia-reperfusion injury; Microcirculation dysfunction; Perfusion quantification

Mesh:

Substances:

Year:  2017        PMID: 28684184     DOI: 10.1016/j.ultrasmedbio.2017.06.004

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  2 in total

1.  Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.

Authors:  Tobias Getzin; Faikah Gueler; Björn Hartleben; Marcel Gutberlet; Anja Thorenz; Rongjun Chen; Martin Meier; Jan Hinrich Bräsen; Thorsten Derlin; Dagmar Hartung; Hannah A S Lang; Hermann Haller; Frank Wacker; Song Rong; Katja Hueper
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

2.  Imaging-based vascular-related biomarkers for early detection of acetaminophen-induced liver injury.

Authors:  Haolu Wang; Leslie J Burke; Jatin Patel; Brian Wc Tse; Kim R Bridle; Victoria C Cogger; Xinxing Li; Xin Liu; Haotian Yang; Darrell H G Crawford; Michael S Roberts; Wenchao Gao; Xiaowen Liang
Journal:  Theranostics       Date:  2020-05-18       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.